GENE ONLINE|News &
Opinion
Blog

Cancer Immunotherapy
Partnerships Takeda PharmaceuticalF-starBispecific Antibody
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Trials & Approvals Incyte CorporationAnti-PD-1
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
R&D Cancer Immunotherapy
Combining STING Agonists and pHLIPs to Enhance Cancer Treatments
2022-11-09
Trials & Approvals Cancer ImmunotherapyRoche
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
Trials & Approvals Cancer
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Trials & Approvals Oncology
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
Licensing Antibody-Drug Conjugate
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
R&D Cancer
Vaccines Against Cancers May Be the Future
2022-05-30
Trials & Approvals Johnson & Johnson
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Trials & Approvals Merck
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Funding Immune Checkpoint Inhibitor
Pheast Gets a $76 Million Series A to Feed Pipeline of Immune Checkpoint Inhibitors
2022-04-27
Feature Blood CancerCancer Immunotherapy
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Trials & Approvals Checkpoint Inhibitor
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
1 2
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top